Correction: Ly et al. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation Against Ovarian Cancer Metastasis. Int. J. Mol. Sci. 2022, 23, 944

Key Points

• To correct an error found in the original publication regarding H&E staining images related to the findings on etravirine's effects.
• Identification of incorrect H&E staining images in Figure 6h.
• Review of original data related to etravirine's effect.
• Correction of visual representation for accuracy.
• Correction needed for representative images.
• No new findings presented regarding etravirine's effects.